A detailed history of Fort Baker Capital Management LP transactions in Axonics, Inc. stock. As of the latest transaction made, Fort Baker Capital Management LP holds 57,590 shares of AXNX stock, worth $4.09 Million. This represents 2.81% of its overall portfolio holdings.

Number of Shares
57,590
Holding current value
$4.09 Million
% of portfolio
2.81%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$67.3 - $69.67 $3.88 Million - $4.01 Million
57,590 New
57,590 $4.01 Million

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Fort Baker Capital Management LP Portfolio

Follow Fort Baker Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fort Baker Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Fort Baker Capital Management LP with notifications on news.